Study: Microdosing LSD for 1 month was followed by improved mood, productivity
Might microdosing LSD and psilocybin be a safe, effective way to treat depression and other disorders?
- A recent study collected the self-reports of more than 1,000 people who microdosed LSD or psilocybin regularly for about a month.
- The results showed that most people experienced more positive moods, less depression and increased productivity.
- These results are preliminary, and microdosing remains an under-researched area.
Microdosing psychedelic drugs on a regular basis might be a safe way to improve your mood and productivity, according to a new study published in the Journal of Psychoactive Drugs.
Microdosing is a practice in which you take a very small or "sub-perceptual" dose of drugs in order to reap the benefits of the drug without experiencing too much of its consciousness-altering effects. In the recent study, researchers collected reports from more than 1,000 participants in 59 countries, most of whom microdosed once every three days for a month. (The researchers defined microdoses as between 7 to 13 micrograms for LSD; 0.1 to 0.4 grams for dried psilocybin mushrooms.)
This microdosing regimen was followed by "improvements in negative moods, especially depression, and increases in positive moods. Increased energy, improved work effectiveness, and improved health habits were observed in clinical and nonclinical populations," the researchers wrote. One participant reported: "Feeling productive, able to focus on what I choose, enjoying relationships, good energy, and not recalling that I took anything."
The preliminary results suggest that "microdosing has none of the classic exciting effects of psychedelics, is safer, and many people all over the world report taking these low doses to be beneficial," study author James Fadiman, who's been researching psychedelics for decades, told PsyPost.
Still, the researchers cautioned against attaching clinical significance to their statistically significant results, which came from self-reports.
"While statistical significance can give us information about a low-level change over a large population — for example, improving one point on the Beck Depression Inventory — this may mean little to people suffering from depression," they wrote. "However, many participants informed us that they found microdosing to be an effective antidepressant, or replacement for their antidepressants. For example, a 70-year-old man writes: 'For the first time in 31 years, I am off antidepressants' and includes descriptions of moments when his emotional range has clearly been expanded."
The researchers also mentioned that the positive results could be explained by the placebo effect. That possibility didn't matter to at least one participant, who wrote: "I don't care if it's a placebo or not, all I know is I haven't felt this good in decades."
Other research on microdosing
Microdosing is far from a new idea. Decades ago, Albert Hoffman, the first scientist to synthesize and ingest LSD, suggested that low doses of LSD might be a suitable replacement for Ritalin. However, like psychedelics in general, scientists still have much to learn about how taking regular small doses of psychedelic drugs affects the body over time. Fortunately, there have been some illuminating studies and reports in recent years that suggest microdosing LSD or psilocybin has the potential to:
- Boost divergent and convergent thinking, both of which are considered fundamental to creativity. (Note: The 2018 study that observed these effects also found that microdosing seemed to have no effect on fluid intelligence.)
- Alleviate anxiety and depression.
- Increase productivity, at least as reported by many in Silicon Valley who've turned to microdosing as sort of the ultimate productivity hack.
Of course, if you're interested in microdosing or experimenting with psychedelic drugs, you should approach them at your own risk. After all, they're not for everybody, as Fadiman told PsyPost.
"People whose major symptom is anxiety should not microdose. Although there are thousands of years of recorded use, there are no contemporary double-blind studies. Inform yourself."
- The Long-Term Effects of Microdosing LSD – Erica Avey – Medium ›
- First ever trials on the effects of microdosing LSD set to begin ... ›
What can 3D printing do for medicine? The "sky is the limit," says Northwell Health researcher Dr. Todd Goldstein.
- Medical professionals are currently using 3D printers to create prosthetics and patient-specific organ models that doctors can use to prepare for surgery.
- Eventually, scientists hope to print patient-specific organs that can be transplanted safely into the human body.
- Northwell Health, New York State's largest health care provider, is pioneering 3D printing in medicine in three key ways.
Riots may ensue as more poor Americans recognize their "miserable" long-term prospects.
- How bad is wealth inequality in the United States? About 1 percent of Americans hold 80 percent of the money.
- In the United States, the correlation between the income of parents and the income of their children when they grow up is higher than in any other country in the world.
- One of the big underlying reasons for poverty is receiving a crummy education, which in turn leads to crummy jobs. When people recognize their miserable long-term prospects, they are more likely to partake in riots.
If you don't want to know anything about your death, consider this your spoiler warning.
- For centuries cultures have personified death to give this terrifying mystery a familiar face.
- Modern science has demystified death by divulging its biological processes, yet many questions remain.
- Studying death is not meant to be a morbid reminder of a cruel fate, but a way to improve the lives of the living.
How many abortions are actually performed? Numbers reveal the complexity in the raging debate.
- The American society is close to split on the legality of abortions.
- 45,789,558 abortions were carried out in the U.S. between 1970 and 2015.
- The abortion numbers are at an all-time low now, trending almost half of what they were.
SMARTER FASTER trademarks owned by The Big Think, Inc. All rights reserved.